Duke Sports Medicine, 280 Frank Bassett Dr., Durham, NC 27710, USA.
Knee Surg Sports Traumatol Arthrosc. 2011 Mar;19(3):462-72. doi: 10.1007/s00167-010-1277-z. Epub 2010 Oct 15.
Many clinical studies and systematic reviews have compared the short-term (2 years) outcomes of ACL reconstruction with hamstring and patellar tendon autograft. Few differences have been observed, with the exception of increased kneeling pain with patellar tendon grafts. The goal of this systematic review is to determine whether there are differences in clinical, patient-reported, or radiographic outcomes based on graft choice at a minimum of 5 years after ACL reconstruction.
A systematic review was performed to identify all prospective outcome studies comparing patellar tendon and hamstring autograft ACL reconstruction with minimum follow-up of at least 5 years. Seven studies were identified and meta-analysis of select data determined to be sufficiently homogenous was performed (failure and laxity).
Five randomized controlled trials and two prospective cohorts comparing hamstring and patellar tendon autografts were identified. Clinical assessment [failure rate, International Knee Documentation Committee (IKDC) class, Lachman, pivot shift, and KT 1000 testing] showed no difference between grafts. Patient-reported outcomes (Lysholm, Cincinnati, and IKDC) showed no difference. Both anterior knee pain (3/3 studies) and kneeling pain (4/4 studies) were more frequent in the patellar tendon group. However, the patient-reported outcomes in these studies were not different. Radiographic evidence of osteoarthritis was inconsistent between autograft choices.
This level II systematic review demonstrates no difference in major clinical results between graft types with the exception of increased anterior knee and kneeling pain. There exists a potential for increased incidence of osteoarthritis in the patellar tendon group but increased sample size is required. These longer-term outcomes are similar to results of prior systematic reviews with two-year follow-up.
许多临床研究和系统评价比较了 ACL 重建中使用腘绳肌腱和髌腱自体移植物的短期(2 年)结果。除了髌腱移植物增加了跪地疼痛外,很少观察到差异。本系统评价的目的是确定在 ACL 重建后至少 5 年时,根据移植物选择是否存在临床、患者报告或影像学结果的差异。
进行了系统评价,以确定所有比较髌腱和腘绳肌腱自体移植物 ACL 重建的前瞻性结果研究,随访时间至少为 5 年。确定了 7 项研究,并对选择的数据进行了meta 分析,以确定其具有足够的同质性(失败和松弛)。
确定了 5 项随机对照试验和 2 项比较腘绳肌腱和髌腱自体移植物的前瞻性队列研究。临床评估(失败率、国际膝关节文献委员会[IKDC] 分级、Lachman、轴移试验和 KT-1000 测试)显示移植物之间无差异。患者报告的结果(Lysholm、Cincinnati 和 IKDC)无差异。髌腱组的前膝疼痛(3/3 项研究)和跪地疼痛(4/4 项研究)更为频繁。然而,这些研究中的患者报告结果并无差异。两种自体移植物选择的影像学证据显示骨关节炎不一致。
该 II 级系统评价表明,除了增加前膝和跪地疼痛外,移植物类型之间在主要临床结果方面没有差异。髌腱组存在骨关节炎发生率增加的潜在风险,但需要更大的样本量。这些更长期的结果与具有 2 年随访的先前系统评价的结果相似。